Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Street

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 19, 2025
The Super Enhancer-Driven Long Noncoding RNA PRKCQ-AS1 Promotes Neuroblastoma Tumorigenesis by Interacting With MSI2 Protein and Is Targetable by Small Molecule CompoundsSujanna Mondal, Pei Y Liu, Janith Seneviratne, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 24, 2019
Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanomaShatha AbuHammad, Carleen Cullinane, Claire Martin, et al.
Cell Death & Disease|March 13, 2021
Preclinical small molecule WEHI-7326 overcomes drug resistance and elicits response in patient-derived xenograft models of human treatment-refractory tumorsChristoph Grohmann, Francesca Walker, Mark Devlin, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 19, 2025
The Super Enhancer-Driven Long Noncoding RNA PRKCQ-AS1 Promotes Neuroblastoma Tumorigenesis by Interacting With MSI2 Protein and Is Targetable by Small Molecule CompoundsSujanna Mondal, Pei Y Liu, Janith Seneviratne, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 24, 2019
Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanomaShatha AbuHammad, Carleen Cullinane, Claire Martin, et al.
Cell Death & Disease|March 13, 2021
Preclinical small molecule WEHI-7326 overcomes drug resistance and elicits response in patient-derived xenograft models of human treatment-refractory tumorsChristoph Grohmann, Francesca Walker, Mark Devlin, et al.
Pageof 2